These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31564453)

  • 1. A nested case-control study measuring pertussis vaccine effectiveness and duration of protection in Manitoba, Canada, 1992-2015: A Canadian Immunization Research Network Study.
    Wilkinson K; Righolt CH; Kwong JC; Schwartz KL; Russell ML; Crowcroft NS; Mahmud SM
    Vaccine; 2019 Nov; 37(48):7132-7137. PubMed ID: 31564453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pertussis vaccine effectiveness in a frequency matched population-based case-control Canadian Immunization Research Network study in Ontario, Canada 2009-2015.
    Crowcroft NS; Schwartz KL; Chen C; Johnson C; Li Y; Marchand-Austin A; Bolotin S; Jamieson FB; Drews SJ; Russell ML; Svenson LW; Simmonds K; Mahmud SM; Kwong JC
    Vaccine; 2019 May; 37(19):2617-2623. PubMed ID: 30967309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of acellular pertussis vaccine and evolution of pertussis incidence in the community of Madrid from 1998 to 2015.
    Latasa P; García-Comas L; Gil de Miguel A; Barranco MD; Rodero I; Sanz JC; Ordobás M; Arce A; Garrido-Estepa M
    Vaccine; 2018 Mar; 36(12):1643-1649. PubMed ID: 29439872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: The NSW Public Health Network case-control study.
    Saul N; Wang K; Bag S; Baldwin H; Alexander K; Chandra M; Thomas J; Quinn H; Sheppeard V; Conaty S
    Vaccine; 2018 Mar; 36(14):1887-1892. PubMed ID: 29501321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand.
    Radke S; Petousis-Harris H; Watson D; Gentles D; Turner N
    Vaccine; 2017 Jan; 35(1):177-183. PubMed ID: 27866766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case-control study to assess the effectiveness of pertussis vaccination during pregnancy on newborns, Valencian community, Spain, 1 March 2015 to 29 February 2016.
    Bellido-Blasco J; Guiral-Rodrigo S; Míguez-Santiyán A; Salazar-Cifre A; González-Morán F
    Euro Surveill; 2017 Jun; 22(22):. PubMed ID: 28598324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acellular pertussis vaccine effectiveness and waning immunity in Alberta, Canada: 2010-2015, a Canadian Immunization Research Network (CIRN) study.
    Bell CA; Russell ML; Drews SJ; Simmonds KA; Svenson LW; Schwartz KL; Kwong JC; Mahmud SM; Crowcroft NS
    Vaccine; 2019 Jul; 37(30):4140-4146. PubMed ID: 31164304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak.
    Witt MA; Katz PH; Witt DJ
    Clin Infect Dis; 2012 Jun; 54(12):1730-5. PubMed ID: 22423127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multisite study of pertussis vaccine effectiveness by time since last vaccine dose from three Canadian provinces: A Canadian Immunization Research Network study.
    Savage RD; Bell CA; Righolt CH; Wilkinson K; Schwartz KL; Chen C; Bolotin S; Deeks SL; Drews SJ; Jamieson FB; Johnson C; Kwong JC; Mahmud SM; Russell ML; Simmonds KA; Svenson LW; Crowcroft NS
    Vaccine; 2021 May; 39(20):2772-2779. PubMed ID: 33875270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the reasons for low pertussis vaccine effectiveness in Ontario, Canada, 2006-2008: a Canadian Immunization Research Network study.
    Hughes SL; Kwong JC; Schwartz KL; Chen C; Johnson C; Li Y; Marchand-Austin A; Bolotin S; Jamieson FB; Drews SJ; Russell ML; Svenson LW; Mahmud SM; Crowcroft NS
    Can J Public Health; 2022 Feb; 113(1):155-164. PubMed ID: 34424508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. fim3-24/ptxP-3 genotype is associated to whooping cough outbreak in Brazilian Midwest: The selection of Bordetella pertussis strains driven by vaccine immunization.
    de Paula VG; de Sousa RS; da Silva RCMR; Alves EG; Caetano AR; Ianella P; de Campos TA
    Infect Genet Evol; 2024 Jul; 121():105599. PubMed ID: 38679113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination.
    Smits K; Pottier G; Smet J; Dirix V; Vermeulen F; De Schutter I; Carollo M; Locht C; Ausiello CM; Mascart F
    Vaccine; 2013 Dec; 32(1):111-8. PubMed ID: 24176499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.
    Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM
    Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiological estimation of the effectiveness of the pertussis vaccination during outbreaks in a community. Les pédiatres et bactériologistes du réseau RENACOQ].
    Baron S; Grimprel E; Daurat G; Cuisinet C; Ponge A; Haeghebaert S; Guiso N; Desenclos JC; Drucker J
    Arch Pediatr; 1997 Aug; 4(8):744-50. PubMed ID: 9337897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pertussis Vaccine Effectiveness in the Setting of Pertactin-Deficient Pertussis.
    Breakwell L; Kelso P; Finley C; Schoenfeld S; Goode B; Misegades LK; Martin SW; Acosta AM
    Pediatrics; 2016 May; 137(5):. PubMed ID: 27244813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort.
    Witt MA; Arias L; Katz PH; Truong ET; Witt DJ
    Clin Infect Dis; 2013 May; 56(9):1248-54. PubMed ID: 23487373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of pertussis vaccination and duration of immunity.
    Schwartz KL; Kwong JC; Deeks SL; Campitelli MA; Jamieson FB; Marchand-Austin A; Stukel TA; Rosella L; Daneman N; Bolotin S; Drews SJ; Rilkoff H; Crowcroft NS
    CMAJ; 2016 Nov; 188(16):E399-E406. PubMed ID: 27672225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimates of pertussis vaccine effectiveness in United States air force pediatric dependents.
    Wolff G; Bell M; Escobar J; Ruiz S
    Vaccine; 2015 Jun; 33(28):3228-33. PubMed ID: 25957071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.